全文获取类型
收费全文 | 2408篇 |
免费 | 277篇 |
国内免费 | 75篇 |
专业分类
儿科学 | 12篇 |
妇产科学 | 4篇 |
基础医学 | 203篇 |
口腔科学 | 4篇 |
临床医学 | 108篇 |
内科学 | 789篇 |
神经病学 | 3篇 |
特种医学 | 256篇 |
外国民族医学 | 17篇 |
外科学 | 165篇 |
综合类 | 240篇 |
现状与发展 | 1篇 |
预防医学 | 51篇 |
药学 | 119篇 |
中国医学 | 33篇 |
肿瘤学 | 755篇 |
出版年
2023年 | 60篇 |
2022年 | 53篇 |
2021年 | 119篇 |
2020年 | 106篇 |
2019年 | 204篇 |
2018年 | 161篇 |
2017年 | 142篇 |
2016年 | 77篇 |
2015年 | 147篇 |
2014年 | 306篇 |
2013年 | 194篇 |
2012年 | 145篇 |
2011年 | 130篇 |
2010年 | 95篇 |
2009年 | 106篇 |
2008年 | 110篇 |
2007年 | 88篇 |
2006年 | 88篇 |
2005年 | 93篇 |
2004年 | 68篇 |
2003年 | 26篇 |
2002年 | 33篇 |
2001年 | 43篇 |
2000年 | 26篇 |
1999年 | 27篇 |
1998年 | 15篇 |
1997年 | 23篇 |
1996年 | 11篇 |
1995年 | 19篇 |
1994年 | 20篇 |
1993年 | 4篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 6篇 |
1989年 | 2篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1908年 | 1篇 |
排序方式: 共有2760条查询结果,搜索用时 15 毫秒
1.
2.
目的探讨Hes1基因对肝细胞癌细胞系Hep1-6细胞增殖、迁移与侵袭的影响。方法通过重组腺病毒载体介导Hes1基因在Hep1-6细胞系中过表达,随后测定细胞克隆形成率、增殖速率及体外迁移与侵袭能力的改变。结果Hep1-6细胞分别感染Ad-Hes1和阴性对照Ad-GFP后,感染Ad-Hes1的细胞系克隆形成数显著少于对照组(P<0.001);感染病毒6天后,CCK-8检测感染Ad-Hes1的细胞系在OD450 nm的吸光度值显著低于对照组(P<0.01);感染Ad-Hes1的细胞系24 h和48 h的划痕愈合率显著低于对照组(P<0.001);感染Ad-Hes1的细胞系在Transwell小室培养48 h后迁移进入Transwell下室的细胞数量显著低于对照组(P<0.001);感染Ad-Hes1的细胞系在铺有Matrigel基质胶的Transwell小室培养48 h后侵袭进入Transwell下室的细胞数量显著低于对照组(P<0.01)。结论Hes1有抑制Hep1-6细胞增殖、迁移与侵袭的作用。 相似文献
3.
circRNA是一种新的内源性RNA,广泛存在于真核细胞中,参与转录或转录后基因表达调控,大部分属非编码RNA,是近几年RNA领域中的研究热点。circRNA主要通过拮抗miRNA来发挥“海绵作用”进而调控靶基因表达,与多种疾病有着密切联系,特别是在肿瘤中发挥重要作用。近年研究发现,circRNA对肝细胞肝癌(hepatocellular carcinoma,HCC)的发生、发展及转移具有重要调控作用。该文就circRNA与肝细胞肝癌关系的研究进展作一阐述。 相似文献
4.
Matthew D. Li Katrina F. Chu Allegra DePietro Vincent Wu Eric Wehrenberg-Klee Omar Zurkiya Raymond W. Liu Suvranu Ganguli 《Journal of vascular and interventional radiology : JVIR》2019,30(3):314-319
Purpose
To evaluate the feasibility of a same-day yttrium-90 (90Y) radioembolization protocol with resin microspheres (including pretreatment angiography, lung shunt fraction [LSF] determination, and radioembolization) for the treatment of hepatocellular carcinoma (HCC) and liver metastases.Materials and Methods
All same-day radioembolization procedures performed over 1 y (February 2017 to January 2018) were included in this single-institutional retrospective analysis, in which 34 procedures were performed in 26 patients (median age, 63 y; 13 women), 19 with liver metastases and 7 with HCC. Yttrium-90 treatment activities were calculated by body surface area method. Tumor imaging response was assessed by Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 for liver metastases and modified RECIST for HCC. Clinical side effects and adverse events were graded per Common Terminology Criteria for Adverse Events version 4.0.Results
All planned cases were technically successful, and no cases were canceled for elevated LSF or vascular anatomic reasons. Pretreatment angiography modified the planned 90Y treatment activity in 1 case in which vascular anatomy required a lobar-dose split into 2 for segmental infusions. In 18% of cases, patients were briefly admitted after the procedure for observation or symptom management. Imaging evaluation of initial efficacy at 1 month demonstrated partial response in 25% and stable disease in 67% of patients with liver metastases and partial/complete response in 43% and stable disease in 14% of patients with HCC. Grade ≥ 3 adverse events occurred in 6% of cases, with no systemic therapy–limiting toxicities. The mean total procedure time was 4.2 hours.Conclusions
A same-day 90Y radioembolization protocol with resin microspheres is feasible in select patients, which can expedite cancer therapy. 相似文献5.
6.
The Clinical and Prognostic Implications of Pluripotent Stem Cell Markers Expression and Their Correlation with the WNT signal pathway in Hepatocellular Carcinoma 下载免费PDF全文
Nisreen A.A. OsmanAlzahraa Ibrahim KhalilRehab Kamal Yousef 《Asian Pacific journal of cancer prevention》2020,21(10):2961-2970
Objectives: This study aimed to investigate the expression of SOX2, SOX9, p53, and β-catenin in hepatocellular carcinoma (HCC) and their correlation with clinicopathological parameters of prognostic importance. Materials and Methods: Seventy-five patients were enrolled in this study. All patients had full clinical and follow-up data and available paraffin blocks. Immunohistochemical analysis was performed and correlated with clinicopathological factors and patient survival. Results: We detected the positive expression of SOX2, SOX9, p53, and β-catenin in 76%, 50.7%, 50.7%, and 77.9% of HCC specimens respectively. All studied markers showed a significant increase in the expression in tumor tissue specimens compared to non-tumor tissue. Both SOX2 and SOX9 expressions were significantly associated with adverse prognostic factors in HCC. Significant positive correlations were found between SOX2 and SOX9 and both p53 and β-catenin expression (r= 0.528, 0.485 and; r = 0.253, 0.327, respectively; p < 0.0001 for both of them). Regarding survival, we found that HCC patients with positive SOX2 and SOX9 expressions had significantly shorter overall survival (p=0.0001, each). Additionally, larger tumor size, tumor grade, high stage, tumor multiplicity, presence of cirrhosis, tumor necrosis, high p53 expression, and positive β-catenin expression were independent predictors of worse survival. A multivariate Cox analysis revealed that tumor grade, stage, p53, and SOX2 expression were independent predictors of unfavorable prognosis in overall survival (p=0.0001, p=0.0001,p=0.033; and p=0.003, respectively). Conclusions: Our findings might provide an insight into SOX2 and SOX9’s role in HCC and suggest that SOX2 might be targeted for HCC therapy. 相似文献
7.
目的:运用生物信息学方法筛选年轻肝细胞癌(hepatocellular carcinoma,HCC)患者特有的关键枢纽基因(Hub gene),并探索其生物学和临床意义。方法:从GEO芯片数据集GSE45267获取年轻(确诊HCC时年龄≤40岁)和年老(确诊HCC 时年龄>40岁)组的HCC组织及正常肝组织数据信息,通过GEO2R和Venn图工具筛选两组的HCC组织相对正常肝组织差异表 达基因(differentially expressed gene,DEG),运用STRING和Cytoscape软件构建年轻组特有差异表达基因的蛋白互作网络并筛 选关键Hub基因及显著模块。利用GEPIA数据库对关键基因进行验证,并通过Kaplan–Meier分析相关HCC患者总生存期。最 后应用DAVID对年轻组特有基因及年轻与年老组共有DEGs进行GO富集分析和KEGG通路分析比较。结果:筛选出年轻组特 有117个上调、179个下调DEGs,构建PPI网络选取出10个连接度最高的基因为Hub基因,其中7个Hub基因集中于第一模块。 GEPIA验证与Kaplan–Meier生存分析提示TYMS、CDC6、BUB1、TPX2、OIP5、KIF23等6个表达上调的Hub基因可能与年轻HCC 癌患者的不良预后相关。功能富集分析显示年轻HCC特有DEGs主要参与ATP结合等生物学过程,并主要富集到了细胞周期S 期;年轻与年老组共有DEGs主要参与环氧酶P450、细胞分裂等生物学过程,并主要富集到细胞周期G2/M期。结论:本研究鉴定 出6个在年轻HCC患者肿瘤组织中特有的显著上调且提示预后不良的Hub基因,可能成为年轻HCC患者潜在的治疗和预后预 测靶点。 相似文献
8.
9.
Ke Cao Can Lu Shuang Han Qiong Zou Jingjing Li Dingfang Xie Siqi He Li Yu Jianda Zhou Xiaowei Peng Peiguo Cao 《International journal of clinical and experimental pathology》2015,8(1):551-559
Girdin has been proven to play a vital role in the process of proliferation, apoptosis, and invasion in various cancer cells, yet the underlying molecular mechanism in primary hepatocellular carcinoma (HCC) has not yet been clarified. Thereafter, we performed immunohistochemistry to detect the expression of Girdin in 40 primary HCC tissues and 30 matched adjacent tissues using hepatic carcinoma tissue microarray. Our data showed that the positive expression rate of Girdin in hepatocellular carcinoma tissues was 67.5%, higher than that found in adjacent tissues of 16.7% (P < 0.05). It closely correlates to tumor size, T stage, TNM stage and Edmondson-Steiner stage (P < 0.05) of HCC patients. After specific small interfering RNA of Girdin was transfected into HepG2 and Huh7.5.1 cells, the proliferation and invasion ability of tumor cells were significantly inhibited. In summary, we suggest that the oncogenic role of Girdin could provide new molecular target for the treatment of HCC. 相似文献
10.
《中国现代医生》2020,58(29):24-27+封三
目的 探讨肝癌组织中LncRNA TINCR 表达水平对术后长期生存的影响。方法 回顾性分析2013 年4 月~2016 年2 月间在本院接受手术治疗的157 例肝细胞肝癌患者的临床资料。RT-PCR 法检测肝癌标本内LncRNA TINCR 表达水平,采用ROC 曲线和Kaplan-Meier 法分析LncRNA TINCR 表达水平对肝癌术后长期生存的影响。结果 肝癌组织LncRNA TINCR 表达水平对术后长期生存预测的曲线下面积(AUC)为0.812,特异度为73.77%,灵敏度为79.17%,最佳判读值为1.89(P<0.0001)。根据ROC 曲线分析结果,将肝癌组织LncRNA TINCR 相对表达水平大于1.89 的93 例(59.24%)患者纳入高表达组,而肝癌组织LncRNA TINCR 相对表达水平小于或等于1.89的64 例(40.76%)患者纳入低表达组。Kaplan-Meier 法生存分析发现高表达组术后3 年内有76 例患者死亡,3 年总生存率为18.28%(17/93);低表达组术后3 年内有20 例患者死亡,3 年总生存率为68.75%(44/64),低表达组3 年总生存率明显优于高表达组(P<0.0001,两组间死亡风险比为3.7534,95%可信区间为2.5158~5.6000)。结论 肝癌组织LncRNA TINCR 表达水平与肝癌术后长期生存显著相关,LncRNA TINCR 表达水平升高则预示着预后不佳。 相似文献